Delivery Order SPE2DB22D7065-SPE2DB25FH3PG
- Not listed
- The Defense Logistics Agency awarded a $2,490.56 firm fixed price delivery order to AmerisourceBergen Drug Corp for XULANE 150-35 mcg/day contraceptive patches (3-count package) with a completion date of August 25, 2025. This non-set-aside competitive award represents a direct fulfillment order issued under AmerisourceBergen's larger pharmaceutical supply contract with DLA. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a $1,638.00 delivery order to AmerisourceBergen Drug Corp for XULANE 150-35 mcg/day transdermal patches (quantity of 3 units) on April 23, 2025, with an ultimate completion date of April 24, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,948.40 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day transdermal patches (3-count package), effective August 26, 2025, with completion targeted for August 27, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performs under this delivery order at its corporate office location....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for $4,418.88 to supply Xulane 150-35 mcg/day transdermal patches (quantity: 3 units). This is a firm fixed price delivery order with no set-aside designation, completed competitively under the company's larger indefinite delivery contract with DLA Troop Support Medical. The order is set to be fulfilled by the ultimate completion date of August 13, 2025, with the place of performance in...
- The Defense Logistics Agency awarded a delivery order valued at $3,793.09 to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-unit supply) on August 27, 2025, with completion scheduled for August 28, 2025. This non-competitive delivery order was placed under firm fixed pricing terms and will be performed at the vendor's corporate headquarters in Conshohocken, Pennsylvania. AmerisourceBergen is a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a $2,870.29 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day transdermal patches (3-count package), with an ultimate completion date of April 22, 2025. This non-set-aside contract represents a direct medical supply procurement to support federal healthcare operations. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor for the Department of Defense's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Xulane 150-35 mcg/day contraceptive patches (3-unit package) with a ceiling value of $2,137.02. This non-competitive delivery order, awarded on September 3, 2025, represents a firm fixed-price transaction with an ultimate completion date of September 4, 2025. The contractor will fulfill this order from its facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a $2,515.05 firm fixed-price delivery order to AmerisourceBergen Drug Corp for XULANE 150-35 mcg/day contraceptive patches (3-count) on August 18, 2025, with completion targeted for August 19, 2025. The order was competitively awarded without set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction under AmerisourceBergen's broader pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,443.24 to AmerisourceBergen Drug Corp for XULANE 150-35 MCG/Day contraceptive patches (3-pack unit) on September 8, 2025, with an ultimate completion date of September 9, 2025. The contract carries firm fixed pricing and was not set-aside. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving...
- The Defense Logistics Agency awarded a delivery order valued at $1,320.39 to AmerisourceBergen Drug Corp for XULANE 150-35 mcg/day transdermal patches (3-count units) on August 19, 2025, with an ultimate completion date of August 20, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- SPE2DB22D7065Indefinite Delivery Contract
- SPE2DB22D7065-SPE2DB25FH3PGDelivery Order
The Defense Logistics Agency awarded a $1,299.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for XULANE 150-35 mcg/day patches (3-unit supply) on September 16, 2025, with completion scheduled for September 17, 2025. This non-set-aside contract is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 comprehensive pharmaceutical supply vehicle running through December 2026 that enables the company to supply medications, vaccines, and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, one of the nation's leading pharmaceutical distributors, has demonstrated substantial capacity fulfilling federal medical procurement requirements through competitive award mechanisms. The company serves critical healthcare needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This particular delivery order for the transdermal contraceptive patch represents a routine pharmaceutical supply transaction within the company's extensive portfolio of federal medical product deliveries, which range from small-value orders to substantial purchases exceeding $45,000 and encompass diverse therapeutic categories including specialty medications, generics, vaccines, and medical devices.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 9/16/25 |